Purpose: To evaluate retrospectively whether the findings from the Cornea Donor Study (CDS) led to changes in the transplantation of corneas from older donors.
T
he Cornea Donor Study (CDS) was designed to determine the effect of corneal donor age on corneal graft survival in moderate risk cases over a 5-year follow-up period. The study found that the outcomes for grafts from 66-to 75-year-old donors were comparable to those from donors aged 65 years or less. 1 The rationale for the CDS was that the practice of transplanting only donors up to age 65, which was prevalent at the onset of the study in 1999, limited the potential pool of donors. 2 The present study was designed to determine whether the CDS and its findings have led to changes in eye banking practices and transplantation of corneas from older donors.
MATERIALS AND METHODS
In June 2009, a survey was sent to 35 eye banks in the United States requesting data on donor age, type of transplant (penetrating keratoplasty vs. endothelial keratoplasty), and placement in the United States versus internationally. Fifteen eye banks provided data for analyses. Two of the 15 eye banks that contributed data did not participate in CDS (Lions Eye Bank of Texas at Baylor College of Medicine and Watson Gailey Eye Bank). The eye banks are listed and a summary of the donor age data they provided are given in Table 1 .
Seven of the 15 responding eye banks (47%) provided a full set of data for the survey period from 1998 to 2009. The data from these eye banks were analyzed by 3 time intervals relative to the duration of the CDS: preceding CDS (1998) (1999) Corneas used as part of the CDS were excluded from this analysis. Results were similar when analysis was adjusted for eye bank (data not shown). Adjustments were made by applying weights corresponding to the percent of data each eye bank contributed in each of the 3 periods. Because of the large sample size in this data set, even differences in donor age too small to be clinically relevant may still be statistically significant. Statistical comparisons of median donor age were performed by Spearman rank correlation tests for time, rank sum tests for location, and percentage of donors aged 66 years or older by logistic regression models. All statistical analyses were conducted using SAS version 9.2 software (SAS Institute, Inc, Cary, NC).
RESULTS
For the 7 eye banks that provided complete data, the percentage of donors aged 66 years or older for tissues distributed within the United States increased from 19% before CDS (1998) (1999) to 21% during CDS (2000) (2001) (2002) (2003) (2004) (2005) (2006) (2007) and 25% after CDS results publication (2008-2009) with a corresponding increase in the median (25th-75th percentile) age from 53 (39-63) to 54 (41-64) and to 57 (46-66), respectively (all Ps , 0.001). Conversely, the opposite trend was observed for tissues distributed internationally over the same periods with the percentage of donors aged 66 years or older falling from 56% to 42% to 34%, respectively. The median age declined from 67 (58-72) to 63 (54-70) to 61 (53-68; Table 2) during the 3 periods (all Ps , 0.001). These data are shown by individual year in Figure 1 .
The 8 eye banks, that provided partial data for the period from 2000 to 2009, demonstrated a minimal change in the percent of corneas from donors aged 66 years or older distributed within the United States during CDS and post-CDS (23% and 24%, respectively; Table 2 ). For the same 2 periods, the percentage of donors aged 66 years or older used internationally dropped from 44% during CDS to 38% after CDS.
Donor age trends over time varied substantially by eye bank (Table 3) . Results were comparable for corneas used in penetrating keratoplasty and endothelial keratoplasty, when analysis was adjusted for recipient location (data not shown).
DISCUSSION
The validation that the use of corneas from older donors does not affect 5-year outcome after transplantation, as determined by the CDS, is only of public health importance if this information leads to a change in corneal surgical and eye banking practices. This survey of eye banks was undertaken to evaluate the potential impact of the CDS before and after the 5-year primary outcomes of the study were published in 2008. 1 The survey found that there was a slight increase in the placement of tissue from older donors (more than 65 years) during CDS before the 5-year results were published and a greater increase after the publication of the results. Although the impact of most clinical trials is not realized until well after the results are publicized, the CDS had the potential to exert an earlier influence on clinical practice because the participation of 80 leading corneal transplant centers and 43 eye banks in the United States mandated a change in the utilization of corneas from older donors by many of the 105 participating surgeons for the 1101 enrolled patients who, before CDS, were reluctant to use tissue from older donors. Such widespread acceptance of the use of corneas from older donors in study participants could have influenced the use of corneas from older donors by these surgeons in nonstudy transplants during the period of CDS even before the results were known.
Attributing the increase in donor age from 1998 to 2009 to the CDS cannot be confirmed by this retrospective survey because other factors may have played a role. CDS enrollment began in 2000 and a small increase in donor age 
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occurred among eye banks participating in CDS in the period during CDS compared with the period preceding CDS. There also was an increase, though, in the donor age of corneas distributed by the 2 eye banks that participated in this survey, but that did not participate in the CDS. This could possibly be attributed to the impact of CDS as awareness of the acceptance of older corneas by the study surgeons became more widespread among nonparticipating eye banks and surgeons. Another potential cause of increased donor age could be the increased demand for corneas for transplantation. Data from the Eye Bank Association of America show a relatively stable number of transplants in the United States from 1998 (35,861) through 2006 (33,962). 3 A sharp increase in the number of transplants in 2007 (39,391) and 2008 (41,652) was brought about by the rapid increase in the performance of endothelial keratoplasty. The decrease in the age of internationally exported donor corneas may merely reflect the increased availability of younger corneas as older corneas are increasingly accepted in the United States, but the cause is uncertain.
Increasing the acceptable upper donor age limit increases the donor supply available to eye banks and surgeons. This increase in the donor age is important as demand for corneal tissue increases, pushed by the widespread success of endothelial keratoplasty and several other new surgical innovations. There are also factors, such as emerging diseases, increasing regulations, and the increasing number of required donor serological tests, which could impact eye bank supply in the future. Increasing the age limits without compromising graft outcomes should benefit patients with corneal disease worldwide.
There are limitations to this study that should be considered when interpreting these results. This analysis was retrospective and depended on the limited availability of data, which were collected in various ways and for various purposes. It is not known whether the 15 eye banks providing data for this study reflect the overall practice, but they do seem to be representative in terms of their geographic and volume diversity. Changes in eye bank procurement age limits during the period of data collection could also have impacted the data. Increased upper age limits may have been instituted by some eye banks for reasons unrelated to CDS.
We were unable to separately analyze data from surgeons who did not participate in the CDS, which may have been a more accurate reflection of the influence of published data on wider clinical practice. The changes in donor age found in this study cannot necessarily be attributed to the CDS. Repeating the survey of eye bank donor distribution data for a longer period after the publication of the 5-year CDS outcomes would be advisable. It should also be noted that the CDS donor criteria, in addition to age, were probably more restrictive than those in general use. The CDS used only donors with endothelial cell densities of at least 2300 cells/mm 2 , with specific requirements for other tissue quality parameters as well. 1, 4 It is probable that donors, of all ages, during the survey period did not meet the CDS criteria. Because of the existing bias, it is possible that older donors not meeting the CDS criteria may not have been used for transplantation. Data to assess this factor were not available. The use of older donors with less than 2300 cells/mm 2 , however, is not disparaged by the CDS findings.
A recommendation for the increased acceptance of the use of corneas from older donors by surgeons and eye banks is supported by the published outcomes of the CDS, which show that graft outcome 5 years after transplantation is not associated with the donor's age. 1 The impact of evidencebased medicine on changes in clinical practice involves a complex process 5 that appears to be happening in corneal transplantation. We see the obvious role for continued education related to the suitability of use of older tissues. With continued education, the prior prejudice toward use of younger tissue should disappear. 
